Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers

Proteomics

Volumn 6, Issue 23, 2006, Pages 6277-6287

  Khwaja, Fatima W ^a   Nolen, John David Larkin ^a   Mendrinos, Savaas E ^a   Lewis, Melinda M ^a   Olson, Jeffrey J ^a   Pohl, Jan ^a   Van Meir, Erwin G ^a   Ritchie, James C ^a   Brat, Daniel J ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Brain tumor; Cerebrospinal fluid; CNS; Glioblastoma; MALDI

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE; CYSTATIN C;

ADULT; AGED; ARTICLE; BRAIN CANCER; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GLIOBLASTOMA; HUMAN; INFLAMMATORY DISEASE; MALE; MALIGNANT NEOPLASTIC DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 33845574438     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200600135     Document Type: Article

References (41)

1. Bigner, S., Johnston, W. W., Acta Cytol. 1981, 25, 461-479.
2. Wasserstrom, W. R., Glass, J. P., Posner, J. B., Cancer 1982, 49, 759-772.
3. Freilich, R. J., Krol, G., DeAngelis, L. M., Ann. Neurol. 1995, 38, 51-57.
4. Wasserstrom, W. R., Schwartz, M. K., Fleisher, M., Posner, J. B., Ann. Clin. Lab. Sci. 1981, 11, 239-251.
5. Nakagawa, H., Kubo, S., Murasawa, A., Nakajima, S. et al.. J. Neurooncol. 1992, 12, 111-120.
6. Malkin, M. G., Posner, J. B., Eur. J. Cancer Clin. Oncol. 1987, 23, 1-4.
7. van Zanten, A. P., Twijnstra, A., Ongerboer de Visser, B. W., van Heerde, P. et al., J. Neurol. Neurosurg. Psychiatr. 1991, 54, 119-123.
8. Bach, F., Bach, F. W., Pedersen, A. G., Larsen, P. M., Dombernowsky, P., Eur. J. Cancer Clin. Oncol. 1989, 25, 1703-1709.
9. Soletormos, G., Bach, F., Clin. Chem. Lab. Med. 2001, 39, 170-172.
10. Lim, M. S., Elenitoba-Johnson, K. S., Lab. Invest. 2004, 84, 1227-1244.
11. Wulfkuhle, J. D., Paweletz, C. P., Steeg, P. S., Petricoin, E. F. III, Liotta, L., Adv. Exp. Med. Biol. 2003, 532, 59-68.
12. Won, Y., Song, H. J., Kang, T. W., Kim, J. J. et al., Proteomics 2003, 3, 2310-2316.
13. Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O. et al., Proteomics 2003, 3, 1486-1494.
14. Chaurand, P., Sanders, M. E., Jensen, R. A., Caprioli, R. M., Am. J. Pathol. 2004, 165, 1057-1068.
15. Rohlff, C., Southan, C., Curr. Opin. Mol. Ther. 2002, 4, 251-258.
16. Zheng, P. P., Luider,T. M., Pieters, R., Avezaat, C. J. et al., J. Neuropathol. Exp. Neurol. 2003, 62,855-862.
17. Raymackers, J., Daniels, A., De Brabandere, V., Missiaen, C. et al., Electrophoresis 2000, 21, 2266-2283.
18. Wulfkuhle, J. D., McLean, K.C., Paweletz, C. P., Sgroi, D. C. et al., Proteomics 2001, 1, 1205-1215.
19. Khwaja, F. W., Duke-Cohan, J. S., Brat, D. J., Van Meir, E. G., Clin. Cancer Res. 2006, in press.
20. Mendrinos, S., Nolen, J. D. L., Styblo, T., Carlson, G. et al., Cancer Cytopathol. 2005, 105, 178-183.
21. Wright, G. L. J., Cazares, L. H., Leung, S.-M., Nasim, S. et al., Prostate Cancer Prostate Dis. 1999, 2, 264-276.
22. Bienvenut, W. V., Sanchez, J. C., Karmime, A., Rouge, V. et al., Anal. Chem. 1999, 71, 4800-4807.
23. Rosenfeld, J., Capdevielle, J., Guillemot, J. C., Ferrara, P., Anal. Biochem. 1992, 203, 173-179.
24. Hubalek, F., Edmondson, D. E., Pohl, J., Anal. Biochem. 2002, 306, 124-134.
25. Yuan, X. R. T., Wood, G., Desiderio, D. M., Electrophoresis 2002, 23, 1185-1196.
26. Sanchez, J. C., Guillaume, E., Lescuyer, P., Allard, L. et al., Proteomics 2004, 4, 2229-2233.
27. Nagai, A., Murakawa, Y., Terashima, M., Shimode, K. et al., Neurology 2000, 55, 1828-1832.
28. Hammack, B., Fung, K., Hunsucker, S., Duncan, M. et al., Mult. Scler. 2004, 10, 245-260.
29. Puchades, M., Hansson, S. F., Nilsson, C. L., Andreasen, N. et al., Brain Res. Mol. Brain Res. 2003, 118, 140-146.
30. Eisenach, J. C., Thomas, J. A., Rauck, R. L., Curry, R., Li, X., Pain 2004, 107, 207-212.
31. Mannes, A. J., Martin, B. M., Yang, H. Y., Keller, J. M. et al., Pain 2003, 102, 251-256.
32. Guillaume, E., Zimmermann, C., Burkhard, P. R., Hochstrasser, D. F., Sanchez, J. C., Proteomics 2003, 3, 1495-1499.
33. Ivanov, S., Liao, S. Y., Ivanova, A., Danilkovitch-Miagkova, A. et al., Am. J. Pathol. 2001, 158, 905-919.
34. Olive, P. L., Aquino-Parsons, C., MacPhail, S. H., Liao, S. Y. et al., Cancer Res. 2001, 61, 8924-8929.
35. Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P. et al., Cancer Res. 2001, 61, 6394-6399.
36. Robertson, N., Potter, C., Harris, A. L., Cancer Res. 2004, 64, 6160-6165.
37. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J. et al., Cancer Res. 2000, 60, 7075-7083.
38. Parkkila, A. K., Herva, R., Parkkila, S., Rajaniemi, H., Histochem. J. 1995, 27, 974-982.
39. Haapasalo, J. A., Nordfors, K. M., Hilvo, M., Rantala, I. J. et al., Clin. Cancer Res. 2006, 12, 2, 473-477.
40. Potter, C. P., Harris, A. L., Br. J. Cancer 2003, 89, 2-7.
41. Konduri, S. D., Yanamandra, N., Siddique, K., Joseph, A. et al., Oncogene 2002, 21, 8705-8712.